DevOps Engineer, Verisian
+ Employee Stock Options Plan
Accelerating drug time-to-market
Open for applications
Accelerating drug time-to-market
1-20 employees
Open for applications
+ Employee Stock Options Plan
1-20 employees
Company mission
To empower researchers and regulators to analyse and monitor studies transparently in real-time, leading to improved and safer therapies for devastating diseases.
Role
Who you are
- We require applicants to be based in the UK/Europe
- Substantial experience architecting and implementing cloud infrastructure and application deployments at scale (Terraform, Kubernetes or similar tools)
- Understanding of networking and experience troubleshooting integrated infrastructures in the cloud (AWS, Azure, GCP)
- Experience building and owning continuous integration, testing, and deployment workflows (Github Actions, Gitlab CI/CD, Jenkins, or similar)
- Experience logging and monitoring infrastructure and applications for health, performance, and security
- Experience building/maintaining data processing workflows using queues and event-driven triggers (Argo)
- Strong understanding of client/server architecture
- Excellent documentation and communication skills
- Understanding of and strong conviction for SRE-principles
- Security first mindset
- We & mission mindset
- Iteration mindset
- “If it’s not in code and documented, it doesn’t exist”-mindset
Desirable
- Cloud Security experience (IAM, network segmentation, hardening of cloud services/containers)
- Security-focused infrastructure as code
- Checkov, Semgrep, OWASP ZAP, Trivy, secrets scanning, or similar
- Experience with regulatory framework implementations (SOC2, ISO 27001, CE+, HIPAA, GDPR, IGx)
What the job involves
- As a DevOps Engineer, you will be responsible for the infrastructure used by our world-class engineering team and our customers
- You will be exposed and expected to work with the latest technologies to build clean, efficient, and performant infrastructure and application deployments in secure cloud environments
- As part of our core team, you will join us in troubleshooting customer issues, finding root causes, and deploying required fixes to ensure maximal performance and uptime
- You will directly contribute to our overall efficiency and success by building and maintaining the rails on which our software is built and brought to our customers
- Our application stack is currently based on Postgres, NextJS.js, Java and Python, and deployed via Kubernetes in the cloud (AWS/Azure)
- We run code and data analysis pipelines based on ANTLR4 and Python orchestrated by Argo Workflows
- Git is where our code lives, and Github Actions is how it gets out into the world
- We monitor our infra with Sentry, Grafana, Prometheus, and Loki
- We are currently expanding our core products: the Verisian Explorer, Validator, and Builder
- Our tooling automatically extracts full dataset and column-level data lineages and dependencies from existing clinical trials to enable validation, understanding, modification, communication, as well as trial code and data reuse
- This means clinical trials are analyzed and validated faster, better, and at lower costs to the benefit of all of humanity
Our take
Drug development times are painfully long, with patients waiting years upon years for new medicines to hit the market. Verisian is hoping to change this, with a range of tools to facilitate faster drug trialling and analysis of results.
The company's products target known pain-points in the clinical trial pipeline. For example, Verisian Builder allows trials to be designed faster by supplying a library of pre-approved modules based on existing studies. Trials can be pooled for analysis with Verisian Pooler, while data can be extracted and virtualised with Verisian Tracer.
Verisian is advancing its mission to streamline clinical trails with the release of its first product, Validator, which traces data lineage in SAS outputs to support automated study validation. Now, the team is focused on developing Builder, an AI-powered tool for designing and validating studies, while expanding partnerships with tier-1 pharmaceutical companies.
Kirsty
Company Specialist at Welcome to the Jungle
Company
Funding (1 round)
Sep 2023
$1.4m
SEED
Total funding: $1.4m
Company HQ
Westminster, London, UK
Leadership
Tomás Sabat
(Co-Founder & CEO)Previously on the Founding Team at Vaticle, where they spent 6 years as COO. Obtained an MPhil from the University of Cambridge.
Henning Kuich
(Co-Founder & CTO)Earned a PhD in Systems Biology from Freie Universität Berlin. Spent 7 years at Bayer Pharmaceuticals, ultimately as Senior Computational Scientist.
Share this job